Postmenopausal BleedingNCT03382145
A Review on the Outcome of Patient Managed in Postmenopausal Bleeding Clinic
An observational study of Postmenopausal Bleeding, run by Chinese University of Hong Kong at 1 site in Hong Kong.
Trial summary
Postmenopausal bleeding (PMB) is a common gynaecological complaint, accounting for up to 5 to 10 % of postmenopausal women being referred to gynaecological outpatient clinic. It also comprised of up to 10% of our outpatient gynaecological referral. Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Postmenopausal Bleeding
- How many people
- 17,956 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Feb 2018to 30 Jul 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: All women with postmenopausal bleeding presented to One-Stop PMB clinic were enrolled for analysis. Menopause was defined as the cessation of menses for more than 1 year.
Who may be able to join
- Menopausal
- postmenopausal bleeding
Who cannot join
- had less than one year of amenorrhoea
- amenorrhoea due to medication
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Review on the Outcome of Patient Managed in One Stop Postmenopausal Bleeding Clinic in New Territories East Cluster, NTEC
Postmenopausal bleeding (PMB) is a common gynaecological complaint, accounting for up to 5 to 10 % of postmenopausal women being referred to gynaecological outpatient clinic. It also comprised of up to 10% of our outpatient gynaecological referral. In general, 60 % of women with postmenopausal bleeding have no organic causes identified, whilst benign causes of PMB includes atrophic vaginitis, endometrial polyp, submucosal fibroid and functional endometrium. However, between 5.7 to 11.5% of women with postmenopausal bleeding have endometrial carcinoma, which is the fourth most common cancer among women, therefore, it is important to investigate carefully to exclude genital tract cancer.
A One-stop postmenopausal bleeding clinic has been established since February, 2002 by the Department of Obstetrics and Gynaecology, New Territories East cluster (NTEC) aiming at providing immediate assessment of women with postmenopausal bleeding in one single outpatient clinic assessment. During the visit, a detailed history was taken in regarding the PMB and usage of hormonal replacement therapy or herbal medicine. A physical examination was performed and a cervical smear was taken if not been taken within a year. Transvaginal ultrasound (TVS) was then performed to measure the endometrial thickness (ET), examining ovaries then followed by an endometrial sampling. An outpatient hysteroscopy was performed only if TVS showed an ET >= 5mm, or an abnormal endometrial appearance or unsatisfactory ET. Benign looking endometrial polyp would be removed during the outpatient hysteroscopy if possible.
Read more
At the moment, there was very limited local data and lack of the long term result. Investigators aim to retrospectively evaluate the clinical outcome of postmenopausal bleeding patients who has attended One Stop Postmenopausal Clinic in order to formulate better care and counseling in future.
Objectives:
- To analyze histopathology in relative to history and ultrasound findings in PMB women presented to One Stop Postmenopausal Bleeding Clinic at NTEC
- To correlate the clinical findings of transvaginal ultrasonography (TVS) with outpatient hysteroscopy and endometrial assessment in The One Stop Postmenopausal Bleeding Clinic
- To identify predictive and prognostic factors in women with PMB for possible use in triaging high risk patients
Read the detailed description
Postmenopausal bleeding (PMB) is a common gynaecological complaint, accounting for up to 5 to 10 % of postmenopausal women being referred to gynaecological outpatient clinic. It also comprised of up to 10% of our outpatient gynaecological referral. In general, 60 % of women with postmenopausal bleeding have no organic causes identified, whilst benign causes of PMB includes atrophic vaginitis, endometrial polyp, submucosal fibroid and functional endometrium. However, between 5.7 to 11.5% of women with postmenopausal bleeding have endometrial carcinoma, which is the fourth most common cancer among women, therefore, it is important to investigate carefully to exclude genital tract cancer.
In the past, often women with PMB require multiple clinic visits in order to reach a final diagnosis. This not only increase the medical cost as a whole, but also imposes an enormous stress and burden on patients, concerning about delayed or overlooked diagnosis of genital tract cancer.
A One-stop postmenopausal bleeding clinic has been established since February, 2002 by the Department of Obstetrics and Gynaecology, New Territories East cluster (NTEC) aiming at providing immediate assessment of women with postmenopausal bleeding in one single outpatient clinic assessment.
During the visit, a detailed history was taken in regarding the PMB and usage of hormonal replacement therapy or herbal medicine. A physical examination was performed and a cervical smear was taken if not been taken within a year. Transvaginal ultrasound (TVS) was then performed to measure the endometrial thickness (ET), examining ovaries then followed by an endometrial sampling. An outpatient hysteroscopy was performed only if TVS showed an ET >= 5mm, or an abnormal endometrial appearance or unsatisfactory ET. Benign looking endometrial polyp would be removed during the outpatient hysteroscopy if possible.
At the moment, there was very limited local data and lack of the long term result. Investigators aim to retrospectively evaluate the clinical outcome of postmenopausal bleeding patients who has attended One Stop Postmenopausal Clinic in order to formulate better care and counseling in future.
Objectives:
- To analyze histopathology in relative to history and ultrasound findings in PMB women presented to One Stop Postmenopausal Bleeding Clinic at NTEC
- To correlate the clinical findings of transvaginal ultrasonography ( TVS) with outpatient hysteroscopy and endometrial assessment in The One Stop Postmenopausal Bleeding Clinic
- To identify predictive and prognostic factors in women with PMB for possible use in triaging high risk patients
Methodology A. Subjects Postmenopausal women who attended the One Stop Postmenopausal Bleeding Clinic since year 2002 B. Methods All women with postmenopausal bleeding presented to One-Stop PMB clinic were enrolled for analysis. Menopause was defined as the cessation of menses for more than 1 year. These patients had a thorough history taken. A physical examination was performed. A vaginal ultrasound was performed to determine uterine dimension, the endometrial thickness (ET) and exclude other adnexal pathology. An Endometrial sampling was taken afterward. An outpatient hysteroscopy , a 2.7mm or 2mm 30 degree rigid hysteroscope was then inserted into the uterine cavity using either CO2 or normal saline as distending medium to identify uterine pathology if TVS showed an ET >= 5mm, or an abnormal endometrial appearance, or unsatisfactory ET. Benign looking endometrial polyps were removed during the outpatient hysteroscopy if possible. The management was determined by the finding on transvaginal ultrasonography and hysteroscopy. If surgery was indicated, appropriate surgery would be booked in the clinic. Patient was discharged from the clinic if the findings were normal. A call-back system was established to recall patients with abnormal pathology. A follow up appointment would be given in case of suspicious pathology or incomplete examination.
The data was transferred into a computer database which will be analyzed. Medical records of all patients who presented to our One- Stop clinic at New Territories East Cluster will be reviewed. Patient's demographic data, presenting symptoms, clinical assessments, investigations and treatments will be collected. If they had operations performed, surgical pathology, if any, will also be reviewed. The outcomes in terms of death or still being alive are also ascertained from the Computerized Medical System.
Data and Analysis Data will be analysed using SPSS 22.0 (SPSS Inc., Chicago, IL, USA) program. For comparison of frequencies, chi-square test or or a two-sided Fishers' exact test will be used where appropriate. The Mann- Whitney U Test will be used to compare nonparametric data and the Kolmogorov-Smirnov test for correlation analysis with P<0.05 as indication of significance.
Implication of Data Postmenopausal bleeding (PMB) is a worrisome symptom that requires urgent investigation because of its association with genital tract malignancy. One-stop postmenopausal bleeding clinic is becoming a trend, which has been effective in reducing the number of hospital visits per patient as well as decreasing patient anxiety (9). The review of the results of our One Stop Clinic which allows us to have better understanding of our patient's characteristics, risk factors and underlying pathologies in causing PMB. These could provide a better local evidence for future clinical use and patient care. The data helps to provide the basis for further improvement and streamlining the service as well as finding new approaches in the organization of the service.
- Conditions
- Postmenopausal Bleeding
- Being tested
- No intervention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
No intervention
| Study group | Role | What they receive |
|---|---|---|
| postmenopausal bleeding women | Retrospective review on outcome of One stop Postmenopausal bleeding clinic in New Territorial Eastern Cluster, Hong Kong. Single group study, no intervention. Receives: Other: No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
To assess any correlation between histolopathology and transvaginal ultrasonography in postmenopausal women at Tertiary centre
To review all Medical records of all patients who presented to our One- Stop clinic at New Territories East Cluster will be reviewed. Patient's demographic data, presenting symptoms, clinical assessments, investigations and treatments will be collected. If they had operations performed, surgical pathology, if any, will also be reviewed.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Dec 2017
- Study start1 Feb 2018
- Primary completion30 Jul 2025
- Study completion30 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Postmenopausal BleedingStudies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 17,956 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, CHEUNG CHUN WAI, Chinese University of Hong Kong
- Investigators
- Chun Wai Cheung, Principal investigator, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03382145
- Sponsor's protocol ID
- CRE 2017.475
- Status last verified
- Nov 2025
- First submitted
- 1 Dec 2017
- Last updated
- 28 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 28 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Review on the Outcome of Patient Managed in One Stop Postmenopausal Bleeding Clinic in New Territories East Cluster, NTEC
- ClinicalTrials.gov ID
- NCT03382145
- Acronym / sponsor ID
- CRE 2017.475
- Conditions
- Postmenopausal Bleeding
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 17,956 participants (actual)
- Lead sponsor
- Chinese University of Hong KongUniversity, hospital or other
- Study start
- 1 Feb 2018 (actual)
- Primary completion
- 30 Jul 2025 (actual)
- Study completion
- 30 Jul 2025 (actual)
- First posted
- 22 Dec 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Postmenopausal bleeding (PMB) is a common gynaecological complaint, accounting for up to 5 to 10 % of postmenopausal women being referred to gynaecological outpatient clinic. It also comprised of up to 10% of our outpatient gynaecological referral. In general, 60 % of women with postmenopausal bleeding have no organic causes identified, whilst benign causes of PMB includes atrophic vaginitis, endometrial polyp, submucosal fibroid and functional endometrium. However, between 5.7 to 11.5% of women with postmenopausal bleeding have endometrial carcinoma, which is the fourth most common cancer among women, therefore, it is important to investigate carefully to exclude genital tract cancer.
A One-stop postmenopausal bleeding clinic has been established since February, 2002 by the Department of Obstetrics and Gynaecology, New Territories East cluster (NTEC) aiming at providing immediate assessment of women with postmenopausal bleeding in one single outpatient clinic assessment. During the visit, a detailed history was taken in regarding the PMB and usage of hormonal replacement therapy or herbal medicine. A physical examination was performed and a cervical smear was taken if not been taken within a year. Transvaginal ultrasound (TVS) was then performed to measure the endometrial thickness (ET), examining ovaries then followed by an endometrial sampling. An outpatient hysteroscopy was performed only if TVS showed an ET >= 5mm, or an abnormal endometrial appearance or unsatisfactory ET. Benign looking endometrial polyp would be removed during the outpatient hysteroscopy if possible.
At the moment, there was very limited local data and lack of the long term result. Investigators aim to retrospectively evaluate the clinical outcome of postmenopausal bleeding patients who has attended One Stop Postmenopausal Clinic in order to formulate better care and counseling in future.
Objectives:
- To analyze histopathology in relative to history and ultrasound findings in PMB women presented to One Stop Postmenopausal Bleeding Clinic at NTEC
- To correlate the clinical findings of transvaginal ultrasonography (TVS) with outpatient hysteroscopy and endometrial assessment in The One Stop Postmenopausal Bleeding Clinic
- To identify predictive and prognostic factors in women with PMB for possible use in triaging high risk patients
Detailed description
Postmenopausal bleeding (PMB) is a common gynaecological complaint, accounting for up to 5 to 10 % of postmenopausal women being referred to gynaecological outpatient clinic. It also comprised of up to 10% of our outpatient gynaecological referral. In general, 60 % of women with postmenopausal bleeding have no organic causes identified, whilst benign causes of PMB includes atrophic vaginitis, endometrial polyp, submucosal fibroid and functional endometrium. However, between 5.7 to 11.5% of women with postmenopausal bleeding have endometrial carcinoma, which is the fourth most common cancer among women, therefore, it is important to investigate carefully to exclude genital tract cancer.
In the past, often women with PMB require multiple clinic visits in order to reach a final diagnosis. This not only increase the medical cost as a whole, but also imposes an enormous stress and burden on patients, concerning about delayed or overlooked diagnosis of genital tract cancer.
A One-stop postmenopausal bleeding clinic has been established since February, 2002 by the Department of Obstetrics and Gynaecology, New Territories East cluster (NTEC) aiming at providing immediate assessment of women with postmenopausal bleeding in one single outpatient clinic assessment.
During the visit, a detailed history was taken in regarding the PMB and usage of hormonal replacement therapy or herbal medicine. A physical examination was performed and a cervical smear was taken if not been taken within a year. Transvaginal ultrasound (TVS) was then performed to measure the endometrial thickness (ET), examining ovaries then followed by an endometrial sampling. An outpatient hysteroscopy was performed only if TVS showed an ET >= 5mm, or an abnormal endometrial appearance or unsatisfactory ET. Benign looking endometrial polyp would be removed during the outpatient hysteroscopy if possible.
At the moment, there was very limited local data and lack of the long term result. Investigators aim to retrospectively evaluate the clinical outcome of postmenopausal bleeding patients who has attended One Stop Postmenopausal Clinic in order to formulate better care and counseling in future.
Objectives:
- To analyze histopathology in relative to history and ultrasound findings in PMB women presented to One Stop Postmenopausal Bleeding Clinic at NTEC
- To correlate the clinical findings of transvaginal ultrasonography ( TVS) with outpatient hysteroscopy and endometrial assessment in The One Stop Postmenopausal Bleeding Clinic
- To identify predictive and prognostic factors in women with PMB for possible use in triaging high risk patients
Methodology A. Subjects Postmenopausal women who attended the One Stop Postmenopausal Bleeding Clinic since year 2002 B. Methods All women with postmenopausal bleeding presented to One-Stop PMB clinic were enrolled for analysis. Menopause was defined as the cessation of menses for more than 1 year. These patients had a thorough history taken. A physical examination was performed. A vaginal ultrasound was performed to determine uterine dimension, the endometrial thickness (ET) and exclude other adnexal pathology. An Endometrial sampling was taken afterward. An outpatient hysteroscopy , a 2.7mm or 2mm 30 degree rigid hysteroscope was then inserted into the uterine cavity using either CO2 or normal saline as distending medium to identify uterine pathology if TVS showed an ET >= 5mm, or an abnormal endometrial appearance, or unsatisfactory ET. Benign looking endometrial polyps were removed during the outpatient hysteroscopy if possible. The management was determined by the finding on transvaginal ultrasonography and hysteroscopy. If surgery was indicated, appropriate surgery would be booked in the clinic. Patient was discharged from the clinic if the findings were normal. A call-back system was established to recall patients with abnormal pathology. A follow up appointment would be given in case of suspicious pathology or incomplete examination.
The data was transferred into a computer database which will be analyzed. Medical records of all patients who presented to our One- Stop clinic at New Territories East Cluster will be reviewed. Patient's demographic data, presenting symptoms, clinical assessments, investigations and treatments will be collected. If they had operations performed, surgical pathology, if any, will also be reviewed. The outcomes in terms of death or still being alive are also ascertained from the Computerized Medical System.
Data and Analysis Data will be analysed using SPSS 22.0 (SPSS Inc., Chicago, IL, USA) program. For comparison of frequencies, chi-square test or or a two-sided Fishers' exact test will be used where appropriate. The Mann- Whitney U Test will be used to compare nonparametric data and the Kolmogorov-Smirnov test for correlation analysis with P<0.05 as indication of significance.
Implication of Data Postmenopausal bleeding (PMB) is a worrisome symptom that requires urgent investigation because of its association with genital tract malignancy. One-stop postmenopausal bleeding clinic is becoming a trend, which has been effective in reducing the number of hospital visits per patient as well as decreasing patient anxiety (9). The review of the results of our One Stop Clinic which allows us to have better understanding of our patient's characteristics, risk factors and underlying pathologies in causing PMB. These could provide a better local evidence for future clinical use and patient care. The data helps to provide the basis for further improvement and streamlining the service as well as finding new approaches in the organization of the service.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| postmenopausal bleeding women | – | Other: No interventionRetrospective review on outcome of One stop Postmenopausal bleeding clinic in New Territorial Eastern Cluster, Hong Kong. Single group study, no intervention. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All women with postmenopausal bleeding presented to One-Stop PMB clinic were enrolled for analysis. Menopause was defined as the cessation of menses for more than 1 year.
Key inclusion criteria (2 listed)
- Menopausal
- postmenopausal bleeding
Key exclusion criteria (2 listed)
- had less than one year of amenorrhoea
- amenorrhoea due to medication
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No interventionNo intervention | Other | postmenopausal bleeding women |
Primary outcome
To assess any correlation between histolopathology and transvaginal ultrasonography in postmenopausal women at Tertiary centre
Time frame: Baseline
To review all Medical records of all patients who presented to our One- Stop clinic at New Territories East Cluster will be reviewed. Patient's demographic data, presenting symptoms, clinical assessments, investigations and treatments will be collected. If they had operations performed, surgical pathology, if any, will also be reviewed.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Nov 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Postmenopausal Bleeding
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Recruiting
Office Hysteroscopy in Postmenopausal Women: A Randomized Trial of Cervical Preparation Strategies
Postmenopausal Women, Intrauterine Diseases
Active, not recruitingObservational study
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Abnormal Uterine Bleeding (AUB), Endometrial Cancer
Not yet recruitingObservational study
Hysteroscopic Findings With Histopathologic Report of Endometrium in Patients With Postmenopausal Bleeding
Postmenopausal Bleeding
RecruitingObservational study
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
Endometrial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chun Wai Cheung principal investigator
Chinese University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Postmenopausal Bleeding, run by Chinese University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To assess any correlation between histolopathology and transvaginal ultrasonography in postmenopausal women at Tertiary centre (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2025.